Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00087672
What this trial is testing

A Phase II Study of CC-5013 in Myelofibrosis

Who this might be right for
Myelofibrosis
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Early research (Phase 1)Study completedNCT00654758
What this trial is testing

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AbbVie 33
Large-scale testing (Phase 3)UnknownNCT03048877
What this trial is testing

Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer

Who this might be right for
Differentiated Thyroid Cancer
Peking Union Medical College Hospital 118
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Testing effectiveness (Phase 2)Ended earlyNCT02104011
What this trial is testing

Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers

Who this might be right for
Renal AngiomyolipomasTuberous Sclerosis
University Hospital, Bordeaux 2
Not applicableStudy completedNCT02843230
What this trial is testing

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

Who this might be right for
Glioblastoma
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT00129337
What this trial is testing

Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Tumors
Peregrine Pharmaceuticals 28
Early research (Phase 1)Study completedNCT01445119
What this trial is testing

A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas

Who this might be right for
Recurrent Gliomas
Eli Lilly and Company 58
Large-scale testing (Phase 3)Ended earlyNCT00934739
What this trial is testing

High-Risk Oral Cavity Cancer

Who this might be right for
Oral Cavity Cancer
National Health Research Institutes, Taiwan 150
Testing effectiveness (Phase 2)Ended earlyNCT04952571
What this trial is testing

Combined Treatment of Camrelizumab and Bevacizumab for Adult Patients with Recurrent Glioblastoma (GBM)

Who this might be right for
Recurrent Glioblastoma
Beijing Sanbo Brain Hospital 3
Early research (Phase 1)Ended earlyNCT01137552
What this trial is testing

Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Amgen 44
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Ended earlyNCT01120158
What this trial is testing

Paclitaxel Plus Bevacizumab for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Not applicableStudy completedNCT01982500
What this trial is testing

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 200
Not applicableNot Yet RecruitingNCT06603974
What this trial is testing

The Efficacy and Safety of Benmelstobart for GC/EGC

Who this might be right for
Gastric Cancer
Xijing Hospital 48
Testing effectiveness (Phase 2)Study completedNCT05673824
What this trial is testing

Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies.

Who this might be right for
Nephrotoxicity
Fudan University 76
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Testing effectiveness (Phase 2)Ended earlyNCT04492033
What this trial is testing

CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Who this might be right for
P1b: Advanced Solid TumorsP2: Biliary Tract Cancer
Handok Inc. 41
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation